Abstract

Paratuberculosis, also referred to as Johne's disease, is a contagious and chronic disease in ruminants caused by Mycobacterium avium subspecies paratuberculosis (MAP) . Few estimates of the genetic variation in measures of susceptibility to MAP are available in the literature and even less have attempted to elucidate the genetic associations between measures of susceptibility to MAP and performance in dairy cattle. The objectives of this study were to estimate the genetic variation in serological response to MAP in 4789 Holstein–Friesian dairy cows from 44 Irish dairy herds, and to quantify its genetic association with performance traits measured in the first three lactations of genetically related animals. Univariate mixed linear and threshold animal models were used to estimate variance components and genetic correlations were estimated using bivariate animal linear mixed models; MAP serological response was treated as a continuous variable and dichotomous variable. The prevalence of MAP in the sample population was 4.4%. This figure cannot be extrapolated to the national dairy herd as the sample population was biased towards herds with increased likelihood of MAP infection. Estimates of heritability for MAP serological response varied from 0.07 to 0.15 depending on the model of analysis and whether serological response was treated as continuous or binary; standard errors varied from 0.024 to 0.062. Genetic correlations between MAP serological response and lactation milk, fat and protein yield were negative or close to zero although not always more than two standard errors from zero; stronger negative genetic correlations were evident in older parity animals. Serological response to MAP was not genetically correlated with milk fat concentration but was positively genetically correlated with milk protein concentration in first lactation and negatively correlated with calving interval. There was little or no genetic association between serological response to MAP and survival. Results from this study corroborate previous international suggestions that selection for reduced serological response to MAP is possible, although this does not necessarily imply a concurrent selection for either reduced prevalence of clinical disease or increased resistance to MAP infection.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call